Skip to Main Content

Author Details

Donghui Cheng
University of California los angeles
2003
50
30
PMIDPaper TitleJournal TitlePublished Year
37399401The RNA-binding proteins hnRNP H and F regulate splicing of a MYC-dependent HRAS exon in prostate cancer cells.Proc Natl Acad Sci U S A2023
37963244Dual-inhibitory domain iCARs improve the efficiency of the AND-NOT gate CAR T strategy.Proc Natl Acad Sci U S A2023
37995683Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation.Cancer Cell2023
37192158IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing.Proc Natl Acad Sci U S A2023
35878026Physical and in silico immunopeptidomic profiling of a cancer antigen prostatic acid phosphatase reveals targets enabling TCR isolation.Proc Natl Acad Sci U S A2022
36548668Identification of Bacterial Communities and Tick-Borne Pathogens in <i>Haemaphysalis</i> spp. Collected from Shanghai, China.Trop Med Infect Dis2022
33205519Ras Homolog Family Member F, Filopodia Associated Promotes Hepatocellular Carcinoma Metastasis by Altering the Metabolic Status of Cancer Cells Through RAB3D.Hepatology2021
34919800HLA-A<sup>⿿</sup>02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses.Cell Rep2021
34841295Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy.Cell Rep Med2021
33431692Droplet-based mRNA sequencing of fixed and permeabilized cells by CLInt-seq allows for antigen-specific TCR cloning.Proc Natl Acad Sci U S A2021
30406400The Long Noncoding RNA HOST2 Promotes Gemcitabine Resistance in Human Pancreatic Cancer Cells.Pathol Oncol Res2020
32086391Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers.Proc Natl Acad Sci U S A2020
30700903T cell antigen discovery via trogocytosis.Nat Methods2019
31801883Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer.Sci Transl Med2019
31495780Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer.Cell Stem Cell2019
31484081Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood.Cell Rep2019
29700125<sup>18</sup>F-FAC PET Selectively Images Liver-Infiltrating CD4 and CD8 T Cells in a Mouse Model of Autoimmune Hepatitis.J Nucl Med2018
30348802Isolation and characterization of NY-ESO-1-specific T cell receptors restricted on various MHC molecules.Proc Natl Acad Sci U S A2018
30287662Reprogramming normal human epithelial tissues to a common, lethal neuroendocrine cancer lineage.Science2018
28190001Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1<sup>+</sup> pre-B ALL.J Exp Med2017
27050099N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells.Cancer Cell2016
27823582Domain-swapped T cell receptors improve the safety of TCR gene therapy.Elife2016
27926864Low CD38 Identifies Progenitor-like Inflammation-Associated Luminal Cells that Can Initiate Human Prostate Cancer and Predict Poor Outcome.Cell Rep2016
27694579Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer.Proc Natl Acad Sci U S A2016
27187721Resection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysis.Liver Int2016
27044116Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay.Proc Natl Acad Sci U S A2016
25605948Genetic engineering of hematopoietic stem cells to generate invariant natural killer T cells.Proc Natl Acad Sci U S A2015
26460041A basal stem cell signature identifies aggressive prostate cancer phenotypes.Proc Natl Acad Sci U S A2015
24224722Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.J Gastroenterol Hepatol2014
25101980Deoxycytidine kinase augments ATM-Mediated DNA repair and contributes to radiation resistance.PLoS One2014
23341289Estrogen and progesterone together expand murine endometrial epithelial progenitor cells.Stem Cells2013
24222661Low levels of circulating estrogen sensitize PTEN-null endometrial tumors to PARP inhibition in vivo.Mol Cancer Ther2013
24013668Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of Ikaros.Nat Immunol2013
23319634Long-term in vivo monitoring of mouse and human hematopoietic stem cell engraftment with a human positron emission tomography reporter gene.Proc Natl Acad Sci U S A2013
22911892Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation.Stem Cells2012
21163928Regulated expression of microRNAs-126/126* inhibits erythropoiesis from human embryonic stem cells.Blood2011
21102429ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1.Leukemia2011
20080663Requirement for deoxycytidine kinase in T and B lymphocyte development.Proc Natl Acad Sci U S A2010
20855612Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium.Proc Natl Acad Sci U S A2010
20484820PET probes for distinct metabolic pathways have different cell specificities during immune responses in mice.J Clin Invest2010
20360765Isolation, cultivation and characterization of adult murine prostate stem cells.Nat Protoc2010
19088204Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics.Proc Natl Acad Sci U S A2008
17185413Isolation and functional characterization of murine prostate stem cells.Proc Natl Acad Sci U S A2007
18079287Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics.Proc Natl Acad Sci U S A2007
17641240Self-renewal and multilineage differentiation in vitro from murine prostate stem cells.Stem Cells2007
16382156Normal immune development and glucocorticoid-induced thymocyte apoptosis in mice deficient for the T-cell death-associated gene 8 receptor.Mol Cell Biol2006
16869753Prostate stem cells and prostate cancer.Cold Spring Harb Symp Quant Biol2005
15505216Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations.Proc Natl Acad Sci U S A2004
12521991Cell context-specific effects of the BCR-ABL oncogene monitored in hematopoietic progenitors.Blood2003
14500898IL-3 receptor signaling is dispensable for BCR-ABL-induced myeloproliferative disease.Proc Natl Acad Sci U S A2003
  • 1 - 50 of 50

Recommended Authors

Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Institute of Biophysics of the Czech Academy of Sciences
Career Start Year 2013
Number of shared co-authors 0
Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire (CHU) Sainte-Justine
Career Start Year 2012
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
2Ontario Institute for Cancer Research
Career Start Year 2009
Number of shared co-authors 1
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 1
Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 2
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 0
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 1
Oncology R&D
Career Start Year 2000
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 1
The Ohio State University
Career Start Year 1997
Number of shared co-authors 1
College of Medicine, The Catholic University of Korea
Career Start Year 1996
Number of shared co-authors 0
University of California Davis Health
Career Start Year 1995
Number of shared co-authors 1
University of Toronto
Career Start Year 1991
Number of shared co-authors 2
University of Colorado Anschutz Medical Campus
Career Start Year 1991
Number of shared co-authors 1
St. Jude Children's Research Hospital
Career Start Year 1989
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 1
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 5
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Career Start Year 1989
Number of shared co-authors 0
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 7
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 4
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 7

Collaborators

University of California los angeles
Co-authored papers 43
University of California los angeles
Co-authored papers 18
Duke University School of Medicine
Co-authored papers 9
University of California los angeles
Co-authored papers 8
University of California los angeles
Co-authored papers 7
Institute of Systems Biology, University of Washington
Co-authored papers 6
University of California Los Angeles (university of california los angeles)
Co-authored papers 6
University of California los angeles
Co-authored papers 5
College of Life Science and Engineering, Southwest Jiaotong University
Co-authored papers 4
Oregon Health and Science University
Co-authored papers 4
Fred Hutchinson Cancer Research Center, USA Clinical Research Division
Co-authored papers 3
University of California los angeles
Co-authored papers 3
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
University of California Los Angeles
Co-authored papers 2
Center for Biomolecular Science and Engineering, University of California
Co-authored papers 2
Harvard Medical School
Co-authored papers 2
University of California at Santa Cruz
Co-authored papers 2
University of California los angeles
Co-authored papers 2
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
University of Florida.
Co-authored papers 1
University of California Los Angeles
Co-authored papers 1
University of California
Co-authored papers 1
University of California, Santa Cruz Genomics Institute
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Institute for Systems Biology, University of Washington
Co-authored papers 1
University of California-Los Angeles
Co-authored papers 1
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Co-authored papers 1